Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  C-Rad AB (publ)    CRAD B   SE0002016352

C-RAD AB (PUBL)

(CRAD B)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

C RAD : Web Presentation Interim Report Q3 2020

10/12/2020 | 02:31am EST

Invitation to join the presentation of the C-RAD Q3 interim report

Date: Thursday October 22, 2020 / kl. 11:00 CET

Venue: Online Presentation

Topic: C-RAD Interim Report Q3 2020

Procedure:

Please register online through the website:  

https://attendee.gotowebinar.com/register/7890477381628997900

After the registration, you will receive a confirmation via email.

A recording of the presentation will be made accessible on the C-RAD website after the presentation.

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
 

https://news.cision.com/c-rad/r/c-rad-web-presentation-interim-report-q3-2020,c3213559

https://mb.cision.com/Main/13008/3213559/1317163.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about C-RAD AB (PUBL)
01/18C RAD : Web Presentation Year-end Report 2020
AQ
2020C RAD : receives order for proton cancer treatment centers in the US
AQ
2020C RAD : Shenzhen proton therapy treatment center selects C-RAD Catalyst™ s..
AQ
2020C RAD : 15 percent growth in order intake and record high operating profit
AQ
2020C RAD : Web Presentation Interim Report Q3 2020
AQ
2020C RAD : Australian customers select C-RAD's cutting edge SIGRT solution
AQ
2020C RAD : Shanghai Proton and Heavy Ion Hospital decides for C-RAD SIGRT solution
AQ
2020C RAD : and Elekta expand cooperation - Elekta to distribute C-RAD's cutting-edg..
AQ
2020C RAD PUBL : Positive operating income in challenging times
AQ
2020C RAD PUBL : RAD Web Presentation Half-Year Report 2020
AQ
More news
Financials
Sales 2019 205 M 24,8 M 24,8 M
Net income 2019 -13,8 M -1,66 M -1,66 M
Net cash 2019 6,83 M 0,82 M 0,82 M
P/E ratio 2019 -98,9x
Yield 2019 -
Capitalization 1 602 M 193 M 193 M
EV / Sales 2018 4,12x
EV / Sales 2019 6,69x
Nbr of Employees 56
Free-Float 66,7%
Chart C-RAD AB (PUBL)
Duration : Period :
C-Rad AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends C-RAD AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Tim Thurn President & Chief Executive Officer
Lars Gunnar Nyberg Chairman
Hakan Axelsson Chief Operating Officer
Henrik Bergentoft Chief Financial Officer
Peter Hamberg Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
C-RAD AB (PUBL)-2.49%190
THERMO FISHER SCIENTIFIC10.48%205 631
DANAHER CORPORATION7.21%169 176
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.14.55%91 552
INTUITIVE SURGICAL, INC.-8.08%88 403
ILLUMINA, INC.13.78%61 466